161 related articles for article (PubMed ID: 10699539)
21. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.
Stein A; Voigt W; Jordan K
Ther Adv Med Oncol; 2010 Jan; 2(1):51-63. PubMed ID: 21789126
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
[TBL] [Abstract][Full Text] [Related]
23. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
Bhattacharya S; Vijayasekar C; Worlding J; Mathew G
Acta Gastroenterol Belg; 2009; 72(3):289-95. PubMed ID: 19902860
[TBL] [Abstract][Full Text] [Related]
24. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
Rosenoff SH
Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
[TBL] [Abstract][Full Text] [Related]
25. Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease.
Robak K; Zambonelli J; Bilinski J; Basak GW
Eur J Gastroenterol Hepatol; 2017 May; 29(5):495-502. PubMed ID: 28067684
[TBL] [Abstract][Full Text] [Related]
26. Diarrhea in liver transplant recipients: etiology and management.
Ginsburg PM; Thuluvath PJ
Liver Transpl; 2005 Aug; 11(8):881-90. PubMed ID: 16035068
[TBL] [Abstract][Full Text] [Related]
27. Guidance on the management of diarrhoea during cancer chemotherapy.
Andreyev J; Ross P; Donnellan C; Lennan E; Leonard P; Waters C; Wedlake L; Bridgewater J; Glynne-Jones R; Allum W; Chau I; Wilson R; Ferry D
Lancet Oncol; 2014 Sep; 15(10):e447-60. PubMed ID: 25186048
[TBL] [Abstract][Full Text] [Related]
28. Management of diarrhea induced by tumors or cancer therapy.
Cascinu S
Curr Opin Oncol; 1995 Jul; 7(4):325-9. PubMed ID: 7578380
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy-induced nausea, vomiting and diarrhea].
Aiba K; Natori K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():355-9. PubMed ID: 25831782
[No Abstract] [Full Text] [Related]
30. Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review.
Cherny NI
J Pain Symptom Manage; 2008 Oct; 36(4):413-23. PubMed ID: 18411014
[TBL] [Abstract][Full Text] [Related]
31. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea.
Muehlbauer PM; Thorpe D; Davis A; Drabot R; Rawlings BL; Kiker E
Clin J Oncol Nurs; 2009 Jun; 13(3):336-41. PubMed ID: 19502193
[TBL] [Abstract][Full Text] [Related]
32. Understanding and managing chemotherapy-induced diarrhea.
Saltz LB
J Support Oncol; 2003; 1(1):35-46; discussion 38-41, 45-6. PubMed ID: 15352641
[TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy-induced stomatitis and diarrhea].
Kadowaki S; Yamaguchi K
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1761-6. PubMed ID: 22083181
[TBL] [Abstract][Full Text] [Related]
34. Diarrhea and the rationale to use Sandostatin.
Peeters M; Van den Brande J; Francque S
Acta Gastroenterol Belg; 2010; 73(1):25-36. PubMed ID: 20458847
[TBL] [Abstract][Full Text] [Related]
35. [Management of chemotherapy-induced mucositis and diarrhea].
Kandabashi K; Sasaki T
Gan To Kagaku Ryoho; 2006 Jan; 33(1):24-8. PubMed ID: 16410693
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal complications of oncologic therapy.
Davila M; Bresalier RS
Nat Clin Pract Gastroenterol Hepatol; 2008 Dec; 5(12):682-96. PubMed ID: 18941434
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review.
Deng C; Deng B; Jia L; Tan H
BMJ Open; 2017 Jun; 7(6):e014916. PubMed ID: 28637728
[TBL] [Abstract][Full Text] [Related]
38. Management of faecal incontinence in graft-versus-host disease.
Woodward S
Br J Nurs; 2012 Jan 26-Feb 8; 21(2):84, 86-8. PubMed ID: 22306636
[TBL] [Abstract][Full Text] [Related]
39. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
[TBL] [Abstract][Full Text] [Related]
40. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.
Harris AG; O'Dorisio TM; Woltering EA; Anthony LB; Burton FR; Geller RB; Grendell JH; Levin B; Redfern JS
Dig Dis Sci; 1995 Jul; 40(7):1464-73. PubMed ID: 7628270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
